Form D · Biotechnology

PLIANT THERAPEUTICS, INC.

South San Francisco, CA · CIK 0001746473

Offering snapshot reported Mar 11, 2020 · SEC filing

Reported sold: $100M
Investors reported: 66
Minimum accepted: $0
First sale: Dec 19, 2019

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$48,240,163 → $100,445,146
Reported investors40 → 66

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Mar 11, 2020	Amendment	$100,445,146	$52,204,983vs Jan 9, 2020	66	SEC filing
Jan 9, 2020	Initial	$48,240,163	No comparison	40	SEC filing
Jul 20, 2018	Initial	$0	No comparison	29	SEC filing
Jul 20, 2018	Amendment	$62,148,314	$62,148,314vs Jul 20, 2018	29	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-357505

Source: Form D, filed Mar 11, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Suzanne Bruhn	Director
Bernard Coulie	Director, Executive
Gayle Crowell	Director
Keith Cummings	Executive
John Curnutte	Director
Neil Exter	Director
Charles Homcy	Director
Barbara Howes	Executive
Hoyoung Huh	Director
Johannes Hull	Executive
Eric Lefebvre	Executive
Kevin Raidy	Director
Smital Shah	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

260 Littlefield Avenue
South San Francisco, CA, 94080